MYTHS - MYocarditis THerapy With Steroids
Part of paid clinical trials in San Diego, California.
- Sponsor
- Niguarda Hospital
- Study ID
- NCT05150704
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Myocarditis Acute
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 69 Years
- Healthy Volunteers
- Not accepted
Interventions
- Methylprednisolone — DRUGPulsed corticosteroid therapy (methylprednisolone 1 g IV qd for 3 days diluted in saline solution 250 mL) on top of standard therapy and maximal supportive care
- saline solution — DRUGPlacebo (saline solution 250 mL IV qd for 3 days) on top of standard therapy and maximal supportive care.
Study Details
This is a phase III, multi-center international, single blind randomized controlled trial to test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on top of maximal support in patients with Acute myocarditis (AM).
Key Dates
- Start date
- Oct 7, 2021
- Status verified
- Jul 2025
- Primary completion
- Mar 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 288 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Experimental armPulsed corticosteroid therapy (methylprednisolone 1 g IV qd for 3 days diluted in saline solution 250 mL) on top of standard therapy and maximal supportive care
- Placebo Comparator: Control armPlacebo (saline solution 250 mL IV qd for 3 days) on top of standard therapy and maximal supportive care.
Primary Outcome Measure
Time from randomization to the first event among: all-cause death, HTx, long-term LVAD implant, need for an upgrading of the t-MCS, VT/VF treated with DC shock, first rehospitalization due to HF or ventricular arrhythmias, or AV block. [ Time Frame: 6 months from patients enrollment ]
Central Contacts
- Enrico Ammirati, MD, PhD+39 0264447791
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Diego | San Diego | California | 92093 | Eric D Adler, MD |
| University of Texas | Houston | Texas | 77204 | Angelo Nascimbene, MD |
| University of Virginia | Charlottesville | Virginia | 22903 | Antonio Abbate, MD |
| Virginia Commonwealth University | Richmond | Virginia | 23284 | Roshanak Markley, MD |
Find similar trials in San Diego, CA
Related Studies
- Abatacept in Immune Checkpoint Inhibitor MyocarditisPHASE3 · Recruiting · Massachusetts General Hospital · Los Angeles, California